Females (N=17) | WB 1 h | WB 2 h | VAS 1 h | VAS 2 h | FLACC 1 h | FLACC 2 h |
---|---|---|---|---|---|---|
PM 1 h | Rho=0.28 |
- | Rho=0.32 |
- | Rho=0.30 |
- |
PM 2 h | - | Rho=−0.23 |
- | Rho=−0.09 |
- | Rho=0.19 |
PM (1 and 2 h) | Rho=−0.03 |
Rho=0.07 |
Rho=0.16 |
Female (n = 17) | Male (n = 16) | p-value |
|
---|---|---|---|
PM 1 h | 0.07 (0.04–0.12) | 0.10 (0.04–0.15) | 0.406 |
PM 2 h | 0.09 (0.06–0.18) | 0.17 (0.08–0.24) | |
p-value |
0.156 | x | |
WB 1 h | 4 (0–4) | 5 (0–8) | 0.612 |
WB 2 h | 2 (0–4) | 2 (0–4) | 0.628 |
p-value |
0.201 | 0.182 | x |
VAS 1 h | 3 (1–5) | 6.5 (1–9) | 0.205 |
VAS 2 h | 1 (1–5) | 2.5 (1–5) | 0.586 |
p-value |
0.450 | 0.052 | x |
FLACC 1 h | 0 (0–1) | 3 (0–5) | 0.059 |
FLACC 2 h | 0 (0–0) | 0 (0–3) | |
p-value |
0.128 | 0.094 | x |
WB | VAS | FLACC | PM | |
---|---|---|---|---|
WB | X | 0.000 | ||
VAS | X | −0.024 | ||
FLACC | X | 0.098 | ||
PM | ′ |
Males (N=16) | WB 1 h | WB 2 h | VAS 1 h | VAS 2 h | FLACC 1 h | FLACC 2 h |
---|---|---|---|---|---|---|
PM 1 h | Rho=0.32 |
- | Rho=−0.12 |
- | Rho=0.29 |
- |
PM 2 h | - | Rho=−0.12 |
- | Rho=−0.10 |
- | Rho=−0.14 |
PM (1 and 2 h) | Rho=−0.04 |
Rho=−0.25 |
Rho=−0.07 |
Variable | Statistics |
---|---|
Gender, N (%) | |
Female | 17 (51.5%) |
Male | 16 (48.5%) |
Age, years | |
Mean±SD | 6.1±3.0 |
Me (Q1–Q3) | 5 (4–8) |
Min–Max | 3–17 |
Otolaryngological procedures | |
Adenoidectomy | 11 (33.3%) |
Adenotonsillotomy | 15 (45.5%) |
Tonsillectomy | 7 (21.2%) |
All (N=33) | WB 1 h | WB 2 h | VAS 1 h | VAS 2 h | FLACC 1 h | FLACC 2 h |
---|---|---|---|---|---|---|
PM 1 h | Rho=0.29 |
- | Rho=0.18 |
- | Rho=0.33 |
- |
PM 2 h | - | Rho=−0.13 |
- | Rho=−0.07 |
- | Rho=0.08 |
PM (1 and 2 h) | Rho=0.00 |
Rho=−0.02 |
Rho=0.10 |